Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized controlled trial of ursodeoxycholic acid for prevention of gallstone recurrence after choledocholithotomy
ChiCTR1900021184Phase 4Recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Feb 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ursodeoxycholic acid in cholelithiasis and choledocholithiasis (2 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoint: Whether the stones recur or not. Started Feb 2019; status: recruiting.
02
Drugs
ursodeoxycholic acid
03
Conditions
cholelithiasischoledocholithiasis
Beyond the preview
Go deeper on ChiCTR1900021184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021184.